Journal article
Genetics of Pancreatic Neuroendocrine Tumors
Hematology/oncology clinics of North America, Vol.36(5), pp.1033-1051
10/01/2022
DOI: 10.1016/j.hoc.2022.07.005
PMID: 36154786
Abstract
Genetic testing is becoming increasingly important in the management of pNETs. Although our knowledge in the field is still evolving, advances in genetic sequencing have increased our understanding of the complex genetic mechanisms underlying pNET formation. Clinicians should consider incorporating genomic testing into treatment paradigms and involving genetic counsellors to help patients and family members with decisions regarding genetic testing, interpretation, and follow-up.
Details
- Title: Subtitle
- Genetics of Pancreatic Neuroendocrine Tumors
- Creators
- Chirayu Mohindroo - The University of Texas MD Anderson Cancer CenterFlorencia McAllister - The University of Texas MD Anderson Cancer CenterAna De Jesus-Acosta - Sidney Kimmel Comprehensive Cancer Center
- Resource Type
- Journal article
- Publication Details
- Hematology/oncology clinics of North America, Vol.36(5), pp.1033-1051
- DOI
- 10.1016/j.hoc.2022.07.005
- PMID
- 36154786
- ISSN
- 0889-8588
- eISSN
- 1558-1977
- Publisher
- Elsevier
- Number of pages
- 19
- Grant note
- MD Anderson Moonshot Programs 1R37CA237384-01A1 / NCI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) RP200173 / CPRIT; Cancer Prevention & Research Institute of Texas Andrew Sabin Family Fellowship V Foundation Translational Award SU2C-AACR-DT25-17 / SU2C-Lustgarten Foundation Pancreatic Cancer Interception Translational Cancer Research Grant
- Language
- English
- Date published
- 10/01/2022
- Academic Unit
- Internal Medicine
- Record Identifier
- 9985177933202771
Metrics
1 Record Views